Welcome to the second edition of RxFiles: Type 2 Diabetes.
Top Diabetes Clinical Pearls
A collection of learnings, pearls, and things that may surprise you.
Screening, Diagnosis, & Approach to Treatment
How to screen for T2DM, risk factors for T2DM, diagnosis tree, and an approach to T2DM therapy
PERSPECTIVES ON: Glycemic Targets
A guide to individualizing glycemic targets for your patient.
Modifiable Risk Factors in Diabetes
Guidelines and FAQs for blood pressure, lipids, ACEI/ARB, ASA, and lifestyle change.
PERSPECTIVES ON: Lifestyle Change
Lifestyle change: the best available treatment for type 2 diabetes.
PERSPECTIVES ON: Diabetes and the Kidneys
A guide to protecting and preserving the kidneys in diabetes.
PERSPECTIVES ON: Diabetes and Heart Failure
A guide to comanaging patients with both diabetes and heart failure.
Key messages for using pharmacotherapy in diabetes.
PERSPECTIVES ON: Metformin
Metformin: first-line, and the backbone of pharmacotherapy.
PERSPECTIVES ON: GLP1 Agonists & SGLT2 Inhibitors
The arguments for and against using GLP1 agonists & SGLT2 inhibitors often and early.
Colour Comparison Chart of Pharmacotherapy
Side-by-side comparisons of diabetes pharmacotherapy using a 'traffic light' approach.
GLP1 Agonist Adverse Effects Infographic
Common, less common, rare, and uncertain adverse effects of GLP1 agonists.
SGLT2 Adverse Effects Infographic
Common, less common, rare, and uncertain adverse effects of SGLT2 inhibitors.
Diabetes Drug Comparison Charts
Efficacy, indications, adverse effects, contraindications, drug interactions, monitoring parameters, dosing, and cost comparisons of diabetes pharmacotherapy.
Weight Loss Pharmacotherapy Chart
Efficacy, indications, adverse effects, contraindications, drug interactions, monitoring parameters, dosing, and cost comparisons of weight loss pharmacotherapy.
Key messages for using insulin in diabetes.
Compares and lists the different disposable and reusable insulin pens.
Insulin Comparison Chart
Side-by-side comparisons of the different BASAL and PRANDIAL insulins available.
Insulin Initiation, Titration, and Follow Up
How to initiate insulin, injection tips and common mistakes, troubleshooting titration, converting between insulins, using insulin to treat corticosteroid hyperglycemia, and travel tips.
Hypoglycemia and Sick Day Management
Treating hypoglcyemia, glucagon drug info, and diabetes 'sick day' guidelines.
PERSPECTIVES ON: Hypoglycemia Risk
How to assess and address a patient's risk of hypoglycemia.
Selecting a Basal Insulin
Comparison of basal insulins by cost, coverage, convenience, and hypoglycemia.
Self Monitoring of Blood Glucose
Guidance on how often patients should self monitor blood glucose, and a comparison of available blood glucose meters.
An overview of the diabetes tools in this book.
Shared Decision Making in Diabetes
A user-friendly approach to helping patients decide which diabetes therapy might be best for them.
The Long Story Short - Infographic
Optimizing the choice and use of insulin needles.
Physical Activity Prescription
Evidence suggests that prescribing physical activity is more powerful than simply talking to patients about it.
SADMANS Patient Handout
A handout guiding patients how to pause, and when to restart, medications that can cause acute kidney injury or other side effects when patients are dehydrated.
Diabetes Patient Booklet
A patient booklet for patients with type 2 diabetes, designed to motivate patients to exercise, take their medications regularly, test their sugars only when needed, inject insulin properly, and hold SADMANS medications when dehydrated.
Landmark Diabetes Trials
An overview of the landmark diabetes trials collected here.
Cardiovascular Outcome Landmark Trials
Describes the population studied, intervention, A1c achieved, and macrovascular outcomes of landmark diabetes cardiovascular outcome trials.
Glycemic Target Landmark Trials
Describes the population studied, intervention, A1c achieved, microvascular outcomes, and macrovascular outcomes of landmark glycemic target trials.
Insulin Landmark Trials
Describes the population studied, intervention, efficacy outcomes, and safety outcomes of landmark insulin trials.
Modifiable Risk Factors Landmark Trials
Describes the population studied, intervention, and results of landmark lipid, ASA, blood pressure, and diabetes prevention trials.